Invention Grant
US07662389B2 Use of serum amyloid A gene in diagnosis and treatment of glaucoma and identification of anti-glaucoma agents
失效
血清淀粉样蛋白A基因在青光眼诊断和治疗中的应用及抗青光眼药物的鉴定
- Patent Title: Use of serum amyloid A gene in diagnosis and treatment of glaucoma and identification of anti-glaucoma agents
- Patent Title (中): 血清淀粉样蛋白A基因在青光眼诊断和治疗中的应用及抗青光眼药物的鉴定
-
Application No.: US11615454Application Date: 2006-12-22
-
Publication No.: US07662389B2Publication Date: 2010-02-16
- Inventor: Abbot F. Clark , Wan-Heng Wang , Loretta Graves McNatt
- Applicant: Abbot F. Clark , Wan-Heng Wang , Loretta Graves McNatt
- Applicant Address: CH Hunenberg
- Assignee: Alcon, Inc.
- Current Assignee: Alcon, Inc.
- Current Assignee Address: CH Hunenberg
- Agent Teresa J. Schultz
- Main IPC: A61K39/00
- IPC: A61K39/00
Abstract:
The present invention provides compositions and methods for treating glaucoma, methods for diagnosing glaucoma, and methods for identifying agents which may be useful in the treatment of glaucoma. More specifically, the present invention describes the use of agents that modulate the expression of serum amyloid A.
Public/Granted literature
Information query
